Brian M. Strem insider trades

Open-market stock purchases and sales by Brian M. Strem, President and CEO at Kiora Pharmaceuticals Inc, from SEC Form 4 filings since Jul 26, 2021.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +5%.

Recent trades

DateStockTradeValue
Jul 1, 2026KPRX Kiora Pharmaceuticals IncSold (not open market)$5K
Apr 1, 2026KPRX Kiora Pharmaceuticals IncSold (not open market)$3.7K
Mar 6, 2026KPRX Kiora Pharmaceuticals IncBought (not open market)—
Mar 6, 2026KPRX Kiora Pharmaceuticals IncBought (not open market)—
Mar 3, 2026KPRX Kiora Pharmaceuticals IncSold (not open market)$481

Companies traded

  • KPRX Kiora Pharmaceuticals Inc: 2 buys, last Jul 1, 2026
  • EYEG Eyegate Pharmaceuticals Inc: other filings, last Jul 26, 2021

Get free alerts when Brian M. Strem files a new trade →